These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 28060759)

  • 1. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
    He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
    Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
    Gao X; Zhang S; Chen Y; Wen X; Chen M; Wang S; Zhang Y
    J Cell Biochem; 2019 Dec; 120(12):19796-19809. PubMed ID: 31338862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
    Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
    Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
    Liu CP; Zhang JH; Zheng SC; Liu J; Guo JC
    Oncol Rep; 2018 Nov; 40(5):2826-2835. PubMed ID: 30226624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
    Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
    Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.